Erratum: NF-?B inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation (Proceedings of the National Academy of Sciences of the United States of America (2013) 110 (9469-9474) DOI: 10.1073/pnas.1300532110);NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 23, 2013, Pages 9469-9474

  Chang, Jia ^a   Liu, Fei ^b   Lee, Min ^a   Wu, Benjamin ^a   Ting, Kang ^a   Zara, Janette N ^c   Soo, Chia ^c   Al Hezaimi, Khalid ^d   Zou, Weiping ^e   Chen, Xiaohong ^f   Mooney, David J ^g   Wang, Cun Yu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

^e UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^f CAPITAL MEDICAL UNIVERSITY   (China)

^g HARVARD UNIVERSITY   (United States)

Author keywords

Adult stem cells; Osteoimmunology; Wnt

Indexed keywords

BETA CATENIN; I KAPPA B KINASE; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; PROTEIN; SMURF1 PROTEIN; SMURF2 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; CELL DIFFERENTIATION; CONTROLLED STUDY; CRANIOFACIAL MORPHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TARGETING; RAT; UBIQUITINATION;

EID: 84878736561     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1313265110     Document Type: Erratum

References (55)

1. Phinney DG, Prockop DJ (2007) Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair - current views. Stem Cells 25(11):2896-2902.
2. Bianco P, et al. (2013) The meaning, the sense and the significance: Translating the science of mesenchymal stem cells into medicine. Nat Med 19(1):35-42.
3. Caplan AI (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213(2):341-347.
4. Levi B, Longaker MT (2011) Concise review: Adipose-derived stromal cells for skeletal regenerative medicine. Stem Cells 29(4):576-582.
5. Teitelbaum SL (2010) Stem cells and osteoporosis therapy. Cell Stem Cell 7(5): 553-554.
6. Fan Z, et al. (2009) BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. Nat Cell Biol 11(8):1002-1009.
7. Tang Y, et al. (2009) TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15(7):757-765.
8. Huebsch N, et al. (2010) Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater 9(6):518-526.
9. Sacchetti B, et al. (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131(2):324-336.
10. Lee CH, Shah B, Moioli EK, Mao JJ (2010) CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J Clin Invest 120(9):3340-3349.
11. Ye L, et al. (2012) Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell 11(1):50-61.
12. Guo J, et al. (2010) Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab 11(2):161-171.
13. Méndez-Ferrer S, et al. (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466(7308):829-834.
14. Bastian O, et al. (2011) Systemic inflammation and fracture healing. J Leukoc Biol 89(5):669-673.
15. Rutherford RB, Gu K (2000) Treatment of inflamed ferret dental pulps with recombinant bone morphogenetic protein-7. Eur J Oral Sci 108(3):202-206.
16. Bhandari M, et al. (2003) Predictors of reoperation following operative management of fractures of the tibial shaft. J Orthop Trauma 17(5):353-361.
17. Recknagel S, et al. (2011) Experimental blunt chest trauma impairs fracture healing in rats. J Orthop Res 29(5):734-739.
18. Reikerås O, Shegarfi H, Wang JE, Utvåg SE (2005) Lipopolysaccharide impairs fracture healing: An experimental study in rats. Acta Orthop 76(6):749-753.
19. Gilbert L, et al. (2002) Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 277(4):2695-2701.
20. Weitzmann MN, Roggia C, Toraldo G, Weitzmann L, Pacifici R (2002) Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 110(11):1643-1650.
21. Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: An inflammatory tale. J Clin Invest 116(5):1186-1194.
22. Krum SA, Chang J, Miranda-Carboni G, Wang CY (2010) Novel functions for NFκB: Inhibition of bone formation. Nat Rev Rheumatol 6(10):607-611.
23. Chang J, et al. (2009) Inhibition of osteoblastic bone formation by nuclear factorkappaB. Nat Med 15(6):682-689.
24. van den Berg WB, Miossec P (2009) IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol 5(10):549-553.
25. Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl): S81-S96.
26. Acharyya S, et al. (2007) Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117(4):889-901.
27. Goetz CA, Baldwin AS (2008) NF-kappaB pathways in the immune system: Control of the germinal center reaction. Immunol Res 41(3):233-247.
28. Lam J, et al. (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106(12): 1481-1488.
29. Novack DV (2011) Role of NF-κB in the skeleton. Cell Res 21(1):169-182.
30. Allison DF, Mayo MW (2010) StIKKing together: Do multiple IKK pathways cooperate in the DNA-damage response? Mol Cell 37(4):453-454.
31. Lacey DC, Simmons PJ, Graves SE, Hamilton JA (2009) Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: Implications for bone repair during inflammation. Osteoarthritis Cartilage 17(6):735-742.
32. Yang F, Tang E, Guan K, Wang CY (2003) IKKβ plays an essential role in the phosphorylation of p65/RelA on serine 536 induced by LPS. J Immunol 170:5630-5635.
33. Park BK, et al. (2007) NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 13(1):62-69.
34. Ghannam S, Pène J, Torcy-Moquet G, Jorgensen C, Yssel H (2010) Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol 185(1):302-312.
35. Ruocco MG, et al. (2005) IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J Exp Med 201(10):1677-1687.
36. Liu F, Kohlmeier S, Wang CY (2008) Wnt signaling and skeletal development. Cell Signal 20(6):999-1009.
37. Kim JB, et al. (2007) Bone regeneration is regulated by wnt signaling. J Bone Miner Res 22(12):1913-1923.
38. Gong Y, et al.; Osteoporosis-Pseudoglioma Syndrome Collaborative Group (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107(4):513-523.
39. Hill TP, Später D, Taketo MM, Birchmeier W, Hartmann C (2005) Canonical Wnt/betacatenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8(5):727-738.
40. Cui Y, et al. (2011) Lrp5 functions in bone to regulate bone mass. Nat Med 17(6): 684-691.
41. Day TF, Guo X, Garrett-Beal L, Yang Y (2005) Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8(5):739-750.
42. Glass DA, 2nd, et al. (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8(5):751-764.
43. Holmen SL, et al. (2005) Essential role of β-catenin in postnatal bone acquisition. J Biol Chem 280(22):21162-21168.
44. Minear S, et al. (2010) Wnt proteins promote bone regeneration. Sci Transl Med 2(29): 29ra30.
45. Gaur T, et al. (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280(39):33132-33140.
46. Kim J, et al. (2010) PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells. Mol Cancer Ther 9(7): 1977-1984.
47. Kaneki H, et al. (2006) Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem 281(7):4326-4333.
48. Xing L, Zhang M, Chen D (2010) Smurf control in bone cells. J Cell Biochem 110(3): 554-563.
49. Cho HH, et al. (2010) NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol 223(1):168-177.
50. Hess K, Ushmorov A, Fiedler J, Brenner RE, Wirth T (2009) TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone 45(2):367-376.
51. Chen Q, et al. (2013) DNA damage drives accelerated bone aging via an NF-kBdependent mechanism. J Bone Miner Res 28(5):1214-1228.
52. Weng LH, et al. (2009) Inflammation induction of Dickkopf-1 mediates chondrocyte apoptosis in osteoarthritic joint. Osteoarthritis Cartilage 17(7):933-943.
53. Cowan CM, et al. (2004) Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 22(5):560-567.
54. Lee M, Chen TT, Iruela-Arispe ML, Wu BM, Dunn JC (2007) Modulation of protein delivery from modular polymer scaffolds. Biomaterials 28(10):1862-1870.
55. Lee M, et al. (2009) Biomimetic apatite-coated alginate/chitosan microparticles as osteogenic protein carriers. Biomaterials 30(30):6094-6101.